FMBTD
RCKT icon

First Midwest Bank Trust Division’s Rocket Pharmaceuticals RCKT Stock Holding History

First Midwest Bank Trust Division’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,179
Closed -$407K – 389
2021
Q1 		$407K Buy
+9,179
New +$504K 0.06% 279

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Midwest Bank Trust Division's RCKT Position: Q2 2021 in Review

First Midwest Bank Trust Division sold out of Rocket Pharmaceuticals (RCKT) in Q2 2021, closing a stake of 9,179 shares — an estimated $407K sold.

First Midwest Bank Trust Division first reported a position in RCKT in Q1 2021 and held it in 1 quarter. The position peaked at $407K in Q1 2021. 150 funds tracked by Wall St. Rank hold RCKT as of Q2 2021.

  • First Midwest Bank Trust Division reported no remaining Rocket Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 9,179 Rocket Pharmaceuticals shares in Q2 2021, an estimated $407K.
  • First Midwest Bank Trust Division first reported a position in Rocket Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • First Midwest Bank Trust Division's Rocket Pharmaceuticals position peaked at $407K in Q1 2021.
  • 150 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q2 2021, filed 8 Jul 2021.